Tolga Tanguler, EVP, Chief Commercial Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 1,959 shares at $310.08 ($607K) on 2026-02-13, disclosed to the SEC on 2026-02-17.
Seasonal sale ($607k) by EVP, Chief Commercial Officer — this insider has traded ALNY in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| ALNY | SELL | 2026-01-14 | $548K | — | Filing → |
| ALNY | SELL | 2025-10-03 | $1.1M | — | Filing → |
| ALNY | SELL | 2025-09-02 | $3.1M | — | Filing → |